or
forgot password

    • cancer clinical trials in aurora, CO

    • Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    University of Colorado Denver, Colorado Sickle Cell Treatment and Research Center
    Aurora, Colorado 80045
    Transfusional Hemosiderosis
    ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    University of colorado Heatlh Sciences Center
    Aurora, Colorado 80045
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Colorado Cancer Center at UC Health Sciences Center
    Aurora, Colorado 80045
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    University of Colorado Cancer Center at UC Health Sciences Center
    Aurora, Colorado 80045
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
    University of Colorado Denver Cancer Center
    Aurora, Colorado 80045
    Adrenocortical Carcinoma
    A Trial of Degarelix in Patients With Prostate Cancer
    Anschutz Cancer Pavillion
    Aurora, Colorado
    Prostate Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    The Medical Center of Aurora
    Aurora, Colorado 80012
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    The Medical Center of Aurora
    Aurora, Colorado 80012
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
    Children's HospitalCenter for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Recurrent or Refractory Pediatric Ependymoma
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    The Medical Center of Aurora
    Aurora, Colorado 80012
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Collection of Bone Marrow From Donors Treated With or Without Filgrastim
    Children's Hospital Colorado Center for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Healthy, no Evidence of Disease
    Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
    Children's Hospital Colorado
    Aurora, Colorado 80045
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    University of Colorado Cancer Center at UC Health Sciences Center
    Aurora, Colorado 80045
    Colorectal Cancer, Metastatic Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    University of Colorado Cancer Center - Anschutz Cancer Pavilion
    Aurora, Colorado 80045
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Colorado Cancer Center - Anschutz Cancer Pavilion
    Aurora, Colorado 80045
    Endometrial Cancer
    A Degarelix Trial in Patients With Prostate Cancer
    University of Colorado School of Medicine
    Aurora, Colorado
    Prostate Cancer
    Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
    The Children's Hospital Center for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Ependymoma
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Univ. Colorado at Denver
    Aurora, Colorado 80045
    Locally Recurrent or Metastatic Breast Cancer
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    University of Colorado Cancer Center - Anschutz Cancer Pavilion
    Aurora, Colorado 80045
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    A Study Of PF-04449913 Administered Alone In Select Solid Tumors
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Solid Tumors
    A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    The Children's Hospital, University of Colorado
    Aurora, Colorado 80045
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood
    AXIOS Stent & Delivery System Study
    Unversity of Colorado Denver
    Aurora, Colorado 80045
    Pancreatic Pseudocyst(s)
    PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Metastatic Renal Cell Carcinoma
    Sevelamer for Reducing Endotoxemia and Immune Activation
    University of Colorado Hospital CRS (6101)
    Aurora, Colorado 80045
    HIV-1 Infection
    A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
    The Children's Hospital, University of Colorado
    Aurora, Colorado 80045
    Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Peripheral T-cell Lymphoma
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    University of Colorado Dept of Oncology
    Aurora, Colorado 80045
    Metastatic or Unresectable Cutaneous Melanoma
    Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
    University of Colorado Dept. of Anschutz Cancer (3)
    Aurora, Colorado 80045
    Anaplastic Lymphoma Kinase (ALK), Non-small Cell Lung Cancer
    Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
    Children's Hospital of Colorado
    Aurora, Colorado 80045
    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
    Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
    University of Colorado Dept of Oncology
    Aurora, Colorado 80045
    Locally Advanced or Metastatic BRAF Mutant Melanoma
    A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
    University of Colorado, Denver
    Aurora, Colorado 80045
    V600-mutated BRAF Unresectable Melanoma, V600-mutated BRAF Metastatic Melanoma, Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor